Myriad Genetics Cash Flow Statement (2009-2026) | MYGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-4.70M	24.60M	-7.60M	-20.50M	-14.10M	-35.10M	-42.30M	-54.70M	-116.10M	-61.30M	-31.20M	-26.00M	-36.70M	-22.10M	-42.50M	-0.10M	-330.50M	-27.40M	-7.90M	-34.10M
Depreciation and Depletion (Quarter)	3.40M	2.60M	3.20M	2.80M	2.80M	2.90M	3.10M	8.70M	2.70M	3.40M	4.30M	4.90M	4.60M	4.80M	5.00M	5.10M	4.90M	4.80M	4.70M	4.70M
Share-based Compensation (Quarter)	8.90M	10.00M	8.40M	10.10M	10.40M	9.40M	8.20M	7.50M	11.20M	11.60M	10.40M	12.00M	14.50M	12.40M	10.90M	9.50M	10.70M	12.20M	2.80M	6.50M
Deferred Taxes (Quarter)	0.30M	-16.30M	-4.30M	-5.90M	-4.70M	-11.40M	-8.80M	0.10M	-0.80M	-1.00M	-2.30M	0.60M	-2.20M	-1.40M	0.20M				0.10M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	1.50M	5.90M	-8.60M	5.10M	0.20M	3.80M	-9.10M	4.90M	0.20M	-4.90M	-0.80M	0.10M	0.10M	12.00M	-12.20M	-0.50M	0.70M	5.90M	1.20M	0.10M
Asset Writedowns and Impairment (Quarter)	1.80M		6.30M	10.70M			6.20M					1.20M	11.60M	0.80M	43.00M		316.70M		2.70M	5.40M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-4.40M	-39.30M	-9.50M	-46.50M	-49.70M	-2.80M	-7.30M	-33.20M	-0.90M	-22.10M	-54.70M	-18.60M	2.60M	0.70M	6.60M	-16.30M	-13.60M	21.10M	10.60M	-15.70M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)	3.30M	3.00M	3.00M	3.10M	2.60M	2.90M	3.10M	2.90M	2.90M	2.80M	2.70M	2.30M	2.10M	2.30M	2.80M	2.80M	2.80M	1.00M	1.10M	1.00M
Depreciation & Amortization (CF) (Quarter)	16.90M	14.20M	13.30M	13.00M	12.90M	13.10M	13.70M	19.40M	13.30M	14.10M	15.10M	15.70M	15.10M	15.60M	14.80M	14.40M	14.10M	12.60M	12.60M	12.50M
Change in Working Capital
Change in Receivables (Quarter)	7.60M	-0.50M	-3.00M	10.50M	8.40M	-6.10M	-2.50M	17.50M	-7.40M	3.60M	-1.20M	3.90M	0.60M	8.20M	-4.00M	-0.80M	16.20M	-19.00M	-2.60M	8.70M
Change in Inventory (Quarter)	3.20M	0.80M	-3.20M	0.20M	-0.10M	4.30M	-1.50M	1.70M	0.60M	2.70M	-3.20M	1.80M	3.10M		1.30M	0.90M	0.30M	2.90M	-0.90M	-2.70M
Change in Account Payables (Quarter)	7.80M	-12.90M	14.00M	-3.20M	-5.00M	7.10M	-2.40M	7.60M	3.10M	-8.50M	-5.90M	6.10M	3.30M	-3.60M	-1.10M		3.60M	-0.80M	-4.20M	5.40M
Change in Accured Expenses (Quarter)	9.00M	62.50M	-14.20M	-35.30M	-47.60M	-0.50M	-2.80M	-6.50M	71.90M	21.20M	-59.40M	-14.60M	-5.50M	6.60M	-27.50M	-12.40M	-16.80M	8.40M	-6.70M	-7.40M
Change in Taxes (Quarter)	0.50M	-18.20M	18.10M	0.40M	0.50M	-1.40M	-0.20M		0.10M	-0.30M	-0.50M	1.40M		-1.30M	-0.60M	-2.10M		-0.50M	-1.80M	-10.00M
Other Working Capital Changes (Quarter)	-7.60M	15.90M	-0.10M	3.00M	-5.30M	4.70M	-4.00M	0.80M	-0.80M	3.00M	-3.20M	2.70M	-1.60M	0.10M	0.30M	2.20M	-1.90M	1.30M	-1.80M	9.70M
Investing Activities
Capital Expenditures (Quarter)	4.50M	3.00M	3.40M	6.30M	6.70M	-13.00M	45.30M	23.50M	18.80M	-35.70M	56.60M	6.70M	5.20M	3.50M	3.60M	5.30M	2.80M	2.80M	4.70M	5.40M
Sales of Property, Plant and Equipment (Quarter)		346.60M
Change in Intangibles (Quarter)												1.90M	3.70M	2.80M	2.30M	3.00M	4.10M	3.40M	1.30M	1.10M
Acquisitions (Quarter)
Divestments (Quarter)		379.10M
Change in Acquisitions & Divestments (Quarter)	9.70M	11.80M	24.30M	17.10M	28.10M	42.40M	40.60M	58.10M	30.60M	15.00M	1.50M	1.50M	2.50M	5.00M
Cash from Investing Activities (Quarter)	1.10M	291.00M	-25.90M	-41.30M	-12.00M	11.40M	-35.60M	34.60M	11.80M	-2.50M	-12.00M	-7.10M	-6.40M	7.50M	-5.90M	-8.30M	-6.90M	-6.20M	-6.00M	-6.50M
Financing Activities
Other financing activities (Quarter)						0.70M									-0.40M				-8.60M
Cash from Financing Activities (Quarter)	-26.50M	-74.50M	-1.10M	-4.80M	2.50M	-3.60M	-2.10M	-4.90M	38.40M	-2.50M	121.90M	-8.80M	2.40M	-3.10M	2.10M	13.60M	2.60M	56.20M	-8.20M	-3.00M
Additional items
Exchange Rate Effect (Quarter)	-0.70M	-0.40M	0.10M	-0.60M	-0.20M	-0.50M	0.70M	0.20M	-0.20M	-0.10M	0.70M	-0.80M	-0.70M	1.20M	-0.70M	0.10M	0.60M		0.10M	-0.10M
Change in Cash (Quarter)	-30.50M	176.80M	-36.40M	-93.20M	-59.40M	4.50M	-44.30M	-3.30M	49.60M	-27.70M	55.90M	-35.30M	-4.40M	8.60M	2.10M	-10.90M	-17.30M	71.10M	-3.50M	-25.30M
Free Cash Flow (Quarter)	-8.90M	-42.30M	-12.90M	-52.80M	-56.40M	10.20M	-52.60M	-56.70M	-19.70M	13.60M	-111.30M	-25.30M	-2.60M	-2.80M	3.00M	-21.60M	-16.40M	18.30M	5.90M	-21.10M
Net Cash Flow (Quarter)	-29.80M	177.20M	-36.50M	-92.60M	-59.20M	5.00M	-45.00M	-3.50M	49.30M	-27.10M	55.20M	-34.50M	-1.40M	5.10M	2.80M	-11.00M	-17.90M	71.10M	-3.60M	-25.20M

Research Tools

Myriad Genetics Cash Flow Statement (2009-2026) | MYGN

Create an account

Sign In

Reset Password